Artificial intelligence–derived splenic response in cardiac positron emission tomography is associated with major adverse cardiovascular events: a multi-site study

Clicks: 2
ID: 329224
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #119 of 123 articles by views in cardiovascular research

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 123 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Abstract Aims Inadequate pharmacologic stress may limit the diagnostic and prognostic accuracy of myocardial perfusion imaging (MPI). The splenic ratio (SR), a measure of stress adequacy, has emerged as a potential imaging biomarker. We developed an artificial intelligence (AI) method to derive SR and evaluated the prognostic value in a large multicentre 82Rb-PET cohort undergoing regadenoson stress testing. Methods and results We retrospectively analysed 16 650 patients from six sites in the REFINE PET registry with clinically indicated MPI and linked clinical outcomes. SR was calculated using fully automated algorithms as the ratio of splenic uptake at stress vs. rest. Patients were stratified by SR into decile groups. The primary outcome was major adverse cardiovascular events (MACE). Survival analysis was conducted using Kaplan–Meier and Cox proportional hazards models adjusted for clinical and imaging covariates, including myocardial flow reserve (MFR ≥2 vs. <2) and presence of ischaemia. The cohort had a median age of 69 years, with 59% male patients. Common risk factors included hypertension (81%), dyslipidaemia (77%), diabetes (35%), and prior coronary artery disease (31%). Median follow-up was 3.4 years. Patients with high SR in the testing cohort (n = 950) had an increased risk of MACE [hazard ratio (HR) 1.19, 95% confidence interval (CI) 1.06–1.34, P = 0.005]. Among testing patients with preserved MFR (≥2; n = 8067), high SR remained independently associated with MACE (HR 1.43, 95% CI 1.20–1.70, P < 0.001). Even among patients with preserved MFR and no ischaemia in the testing cohort(MFR≥2, SDS<2; n = 6508), high SR remained independently associated with MACE (HR 1.54 95% CI 1.26–1.88, P < 0.001). Conclusion Elevated AI-derived SR was independently associated with adverse cardiovascular outcomes, including among patients with preserved MFR. These findings support SR as a novel, automated imaging biomarker for risk stratification in 82Rb PET MPI.
Reference Key
openalex_W7213673153 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Giselle Ramirez, Naga Dharmavaram, Aakash Shanbhag, Robert J H Miller, Paul Kavanagh, Jirong Yi, Mark Lemley, Valerie Builoff, Anna Marcinkiewicz, Damini Dey, Jon Hainer, Samuel Wopperer, Stacey Knight, Viet T. Le, Steve Mason, Erick Alexanderson, Isabel Carvajal-Juarez, René R S Packard, Thomas Rosamond, Mouaz H Al-Mallah, Leandro Slipczuk, Mark I. Travin, Wanda Acampa, Andrew J. Einstein, Panithaya Chareonthaitawee, Daniel S. Berman, Marcelo F Di Carli, Piotr J. Slomka
Journal cardiovascular research
Year 2026
DOI
10.1093/cvr/cvag184
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.